Theory and practice of site-specific drug delivery

Gardner, 1985, Potential and limitations of drug targeting: an overview, Biomaterials, 6, 153, 10.1016/0142-9612(85)90003-1 Winther, 1985, Recombinant DNA techniques in the pharmaceutical industry, Med. Lab. Sci., 42, 388 Lowe, 1983, Applications of recombinant DNA technology of interest to medicinal chemists, Annu. Rep. Med. Chem., 18, 308 Pettersson, 1986, Recombinant DNA and the clinics, Ann. Clin. Res., 18, 217 Caskey, 1987, Disease diagnosis by recombinant DNA methods, Science, 236, 1223, 10.1126/science.3296189 Cooper, 1987, Human gene cloning and disease analysis, Lancet, 1, 273, 10.1016/S0140-6736(87)90090-0 Chirigos, 1985, Immunotherapeutic agents: their role in cellular immunity and their therapeutic potential, 8, 327 Talmadge, 1986, Biological response modifiers: realising their potential in cancer therapeutics, Trends Pharmacol. Sci., 277, 10.1016/0165-6147(86)90352-4 Tomlinson, 1986, (Patho)physiology and the temporal and spatial aspects of drug delivery, 1 Baumler, 1984 Ghose, 1969, Radiosensitisation of Ehrlich ascites tumour cells by a specific antibody, Nature (Lond.), 222, 993, 10.1038/222993a0 Ringsdorf, 1975, Structure and properties of pharmacologically active polymers, 135 Sinkula, 1985, Sustained drug action accomplished by the prodrug approach, 167 O'Mullane, 1987, Biopharmaceutics of muparticulate drug carriers, Ann. New York Acad. Sci., 10.1111/j.1749-6632.1987.tb45796.x Tomlinson, 1987, Biological opportunities for site-specific drug delivery using colloids Weisiger, 1986, The hepatic sinusoid is not well-stirred: estimation of the degree of axial mixing by analysis of lobular concentration gradients formed during uptake of thyroxine by the perfused rat liver, J. Pharm. Sci., 75, 233, 10.1002/jps.2600750304 Vera, 1984, Tc-99m-galactosyl-neoglycoalbumin: in vivo characterisation of receptor-mediated binding to hepatocytes, Radiology, 151, 191, 10.1148/radiology.151.1.6701314 Stella, 1980, Pro-drugs and site-specific drug delivery, J. Med. Chem., 23, 1275, 10.1021/jm00186a001 Stella, 1985, Prodrugs: a chemical approach to targeted drug delivery, 247 Bodor, 1981, Site-specific sustained release of drugs to the brain, Science, 221, 65, 10.1126/science.6857264 Levy, 1987, Targeted drug delivery — some pharmacokinetic considerations, Pharm. Res., 4, 3, 10.1023/A:1016413523833 Urquhart, 1985, Delivery systems and pharmacodynamics in new drug research and development, World Biotech. Rep., 2, 321 McIntosh, 1984, The importance of timing in hormone and drug delivery, Trends Pharmacol. Sci., 5, 429, 10.1016/0165-6147(84)90494-2 Ghose, 1972, Antibody as carrier of chlorambucil, Cancer, 29, 1398, 10.1002/1097-0142(197205)29:5<1398::AID-CNCR2820290542>3.0.CO;2-D Rogers, 1971, Hepatic uptake of proteins coupled to fetuin glycopeptide, Biochem. Biophys. Res. Comm., 45, 622, 10.1016/0006-291X(71)90462-1 Rowland, 1975, Suppression of tumour growth in mice by a drug-antibody conjugate using a novel approach to linkage, Nature, 255, 487, 10.1038/255487a0 Szekerke, 1972, The use of macromolecules as carriers of cytotoxic groups (Part 1), 19, 199 Trouet, 1972, Chemotherapy through lysosomes with a DNA-daunorubicin complex, Nature (New Biol), 239, 110, 10.1038/newbio239110a0 Sessa, 1969, Formation of an artificial lysozome, J. Clin. Invest., 48, 76a Gregoriadis, 1971, Enzyme entrapment in liposomes, FEBS Lett., 14, 95, 10.1016/0014-5793(71)80109-6 Kramer, 1976, Albumin muspheres as vehicles for achieving specificity in drug delivery, J. Pharm. Sci., 63, 1646, 10.1002/jps.2600631044 Tomlinson, 1983, musphere delivery systems for drug targeting and controlled release, Int. J. Pharm. Technol. Prod. Manuf., 4, 49 Poste, 1983, Site-specific (targeted) drug delivery in cancer chemotherapy, Biotechnology, 1, 869, 10.1038/nbt1283-869 Poznansky, 1984, Biological approaches to the controlled delivery of drugs: A critical review, Pharmacol. Rev., 36, 277 1984 Friend, 1987, Site-specific drug delivery, Med. Res. Rev., 7, 53, 10.1002/med.2610070104 Strosberg, 1985, Recognition of physiological receptors by anti-idiotypic antibodies, molecular mimicry of the ligand or cross-reactivity?, Curr. Topics mubiol. Immunol., 119, 91 Shai, 1987, Anti-sense peptide recognition of sense peptides: direct quantitative characterisation with the ribonuclease S-peptide system using analytical high performance affinity chromatography, Biochemistry 1987, 26, 669, 10.1021/bi00377a002 Toonen, 1983, Immunoglobulins as targeting agents for liposome encapsulated drugs, Pharmaceutisch Weekblad, 5, 269, 10.1007/BF02074854 Bundgaard, 1985 Keogh-Bennett, 1986, Intracellular delivery and release of fluorescein from an acid-lahile transferrin conjugate, Biochem. Soc. Trans., 15, 444, 10.1042/bst0150444 Worrell, 1986, Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats, Anticancer Drug Des., 1, 179 Burger, 1985, Albumin muspheres for intraarterial tumour targeting, 23, 333 Burgess, 1987, Potential use of albumin muspheres as a drug delivery system, 39, 129 Tomlinson, 1984, Human serum albumin muspheres for intra-arterial drug targeting of cytostatic compounds, 75 Sokoloski, 1984, Drug entrapment within native albumin beads, 295 Straubinger, 1985, pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules, FEBS Lett., 179, 148, 10.1016/0014-5793(85)80210-6 Bassett, 1986, Use of temperature-sensitive liposomes in the selective delivery of methotrexate and cis-platinum analogues to murine bladder tumour, J. Urol., 135, 612, 10.1016/S0022-5347(17)45761-2 Hashida, 1984, Specific delivery of mitomycin c: combined use of prodrugs and spherical delivery systems, 281 Hopkins, 1986, Site-specific drug delivery — cellular opportunities and challenges, 27 Horwich, 1986, Targeting of pre-ornithine transcarbamylase to mitochondria: definition of critical regions and residues in the leader peptide, Cell, 44, 451, 10.1016/0092-8674(86)90466-6 Eppstein, 1985, Epidermal growth factor receptor occupancy inhibits vaccinia virus infection, Nature, 318, 663, 10.1038/318663a0 Marsh, 1987, Vaccinia virus and the epidermal growth factor receptor: a portal for infectivity?, J. Cell Biochem., 34, 239, 10.1002/jcb.240340403 Gershoni, 1986, Protein blot analysis of virus receptors: identification and characterisation of the Sendai virus receptor, Biochim. Biophys. Acta, 856, 19, 10.1016/0005-2736(86)90004-0 Inada, 1984, Mouse Ia antigens are receptors for lactate dehydrogenase virus, Nature, 309, 59, 10.1038/309059a0 Inada, 1985, Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus, J. Gen. Virol., 66, 1469, 10.1099/0022-1317-66-7-1469 Dalgleish, 1984, The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature, 312, 763, 10.1038/312763a0 Armstrong, 1984, Research developments in AIDS, Med. J. Austr., 141, 556, 10.5694/j.1326-5377.1984.tb113135.x 1986 Harris, 1986, Biopharmaceutical aspects of the intranasal administration of peptides, 191 McMartin, 1986, Routes of administration for polar compounds of moderate molecular weight with particular reference to analogues of somatostatin, 255 Morimoto, 1985, Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel, J. Pharm. Pharmacol., 37, 134, 10.1111/j.2042-7158.1985.tb05024.x Dearden, 1971, A new buccal absorption model, J. Pharm. Pharmacol., 23S, 68S, 10.1111/j.2042-7158.1971.tb08771.x Merkle, 1986, Drug delivery of peptides: the buccal route, 159 Westergaard, 1974, Delineation of the dimensions and permeability characteristics of the two major diffusion barriers to passive mucosal uptake in the rabbit intestine, J. Clin. Invest., 54, 718, 10.1172/JCI107810 De Meere, 1984, Physicochemical description of rates of drug absorption between water and 2,2,4-trimethylpentane, Int. J. Pharm., 22, 177, 10.1016/0378-5173(84)90020-6 Chiang, 1987, Gastrointestinal uptake of liposomes I, 37, 75 Saffron, 1986, A new approach to the oral administration of insulin and other peptide drugs, Science, 233, 1081, 10.1126/science.3526553 Matsuno, 1983, Uptake by enterocytes and subsequent translocation to internal organs, e.g., the thymus, of percoll muspheres administered per os to suckling mice, RES: J. Reticuloendothelial Soc., 33, 263 Sanders, 1961, A study of particulate intestinal absorption and hepatocellular uptake: use of polystyrene latex particles, Exp. Cell Res., 22, 137, 10.1016/0014-4827(61)90092-1 Damge, 1987, Polyalkylcyanoacrylate nanocapsules increase the intestinal absorption of a lipophilic drug, Int. J. Pharm., 36, 121, 10.1016/0378-5173(87)90146-3 Aprahamian, 1987, Les vecteurs colloidaux polymériques (nanocapsules) franchissent-ils la barrière intestinale?, 175 Kimura, 1985, Intestinal absorption of liposomally-entrapped drugs, Saishin Igaku, 40, 1818 Patel, 1985, Intracellular digestion of saturated and unsaturated phospholipid liposomes by mucosal cells, 839, 40 Nefzger, 1984, Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats, J. Pharm. Sci., 73, 1309, 10.1002/jps.2600730934 Owen, 1986, M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for mubial transepithelial migration, J. Infect. Dis., 153, 1108, 10.1093/infdis/153.6.1108 Bockman, 1973, Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix and Peyer's patches, 136, 455 Wolf, 1981, Intestinal M cells: a pathway for entry of reovirus into the host, Science, 212, 471, 10.1126/science.6259737 Joel, 1978, Distribution and fate of ingested carbon particles in mice, J. Reticuloendothelial Soc., 72, 440 Muranishi, 1986, Enhanced absorption and lymphatic transport of macromolecules via the rectal route, 177 Dingle, 1978, Novel treatment for joint inflammation, Nature, 271, 327, 10.1038/271372a0 Hollander, 1951, Hydrocortisone and cortisone injected into arthritic joints, 147, 1629 Shaw, 1976, Liposomal retention of a modified anti-infammatory steroid, Biochem. J., 158, 473, 10.1042/bj1580473 Noble, 1983, Leakage of radioactive particle systems from a synovial joint studied using a gamma camera: its application to radiation synovectomy, J. Bone Joint Surg., 65A, 381, 10.2106/00004623-198365030-00014 Ratcliffe, 1984, musphere systems for intraarticular drug administration, 345 Ratcliffe, 1984, Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs, J. Pharm. Pharmacol., 36, 431, 10.1111/j.2042-7158.1984.tb04419.x Fehr, 1985, Intraarticular injection of corticosteroid-containing liposomes into normal and arthritic knee joints of rabbits, Therapiewoche, 35, 2986 Weinstein, 1979, Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumours, Science, 204, 188, 10.1126/science.432641 Ranney, 1986, Drug targeting to the lungs, Biochem. Pharmacol., 35, 1063, 10.1016/0006-2952(86)90140-1 Snipes, 1984, Disposition of 3-, 7-, and 13-μm muspheres instilled into lungs of dogs, Environ. Res., 33, 333, 10.1016/0013-9351(84)90031-8 Lehnert, 1986, Translocation of particles to the tracheobronchial lymph nodes after lung disposition: kinetics and particle-cell realtionships, Exp. Lung Res., 10, 245, 10.3109/01902148609061496 Juliano, 1980, Controlled delivery of an anti-tumour drug: localised action of liposome encapsulated cytosine arabinoside administered via the respiratory tract, J. Pharmacol. Exp. Ther., 214, 381 Farr, 1985, 99m-Technetium as a marker of liposomal deposition and clearance in the human lung, Int. J. Pharmaceutics, 26, 303, 10.1016/0378-5173(85)90239-X Mufson, 1985, The application of liposome technology to targeted delivery systems, Pharm. Technol., 16 Carman-Meakin, 1986, A liposomal sustained-release aerosol delivery system, Int. Patent Appl. No. WO 86/01714 Gurny, 1985, Ocular therapy with nanoparticulate systems for controlled drug delivery used via the ocular route, J. Controlled Release, 2, 353, 10.1016/0168-3659(85)90057-4 Hara, 1985, Phagocytosis of polystyrene spheres in the rabbit corneal endothelium: contribution of lysosomal enzymes to the endothelial degeneration, Ophthalmol. and Visual Sci., 26, 1631 Algvere, 1985, Sequelae of intravitreal phagocytic activity in response to muparticles, Acta Ophthmal., 63, 107, 10.1111/j.1755-3768.1985.tb06862.x Illum, 1986, muspheres as a potential controlled release nasal drug delivery system, 205 Gruber, 1987, Some biological issues in oral, controlled delivery, Adv. Drug Delivery. Rev., 1, 1, 10.1016/0169-409X(87)90066-4 Klipstein, 1983, Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by muspheres, Infect. Immun., 39, 1000, 10.1128/IAI.39.2.1000-1003.1983 McLaughlin, 1983, Local chemo- and immunotherapy by intratumor drug injection: opportunities for polymer-drug compositions, 231 Leak, 1971, Studies on the permeability of lymphatic capillaries, J. Cell. Biol., 50, 300, 10.1083/jcb.50.2.300 Leak, 1986, Distribution of cell surface charges on mesothelium and lymphatic endothelium, muvasc. Res., 31, 18 Bergqvist, 1984, The characterisation of radiocolloids used for administration to the lymphatic system, 263 Taylor, 1984, Exchange of macromolecules across the mucirculation, Handbook Physiol., 6, 467 Poste, 1983, Liposome targeting in vivo: problems and opportunities, Biol. Cell, 47, 19 Casley-Smith, 1977, Lymph and lymphatics, Vol. I, 423 Weinstein, 1984, Liposomes as drug carriers in cancer chemotherapy, Pharmac. Ther., 24, 207, 10.1016/0163-7258(84)90035-4 Weinstein, 1986, Selected issues in the pharmacology of monoclonal antibodies, 81 Hirano, 1985, Lymphatic transport of liposome-encapsulated drugs following intraperitoneal administration — effect of lipid composition, Pharm. Res., 2, 271, 10.1023/A:1016337500364 Mangat, 1985, Lymph node localisation on non-specific antibody-coated liposomes, Life Sci., 36, 1917, 10.1016/0024-3205(85)90440-0 Nakatsu, 1979, Uptake of liposome-entrapped mannitol by diaphragm, Can. J. Physiol. Pharmacol., 57, 756, 10.1139/y79-115 Ellens, 1981, In vivo fate of large multilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intraveneous injection into rats, Biochim. Biophys. Acta, 674, 10, 10.1016/0304-4165(81)90341-X Davis, 1987, Chemically cross-linked albumin muspheres for the controlled release of incorporated rose bengal after intramuscular injection into rabbits, J. Controlled Res., 4, 293, 10.1016/0168-3659(87)90021-6 Martodam, 1979, Albumin muspheres as carrier of an inhibitor of leukocyte elastase: potential therapeutic agent for emphysema, 76, 2128 Torchilin, 1983, Immobilized enzymes and the use of immobilization principles for drug targeting, 127 Lindberg, 1984, Biodegradable starch muspheres, 153 Blanchard, 1965, Blood supply to hepatic V2 carcinoma implants as measured by radioactive muspheres, 118, 465 Lindell, 1977, The circulation in liver tissue and experimental liver metastases before and after embolism of the liver artery, Res. Exp. Med., 171, 63, 10.1007/BF01851589 Gregoriadis, 1977, Fate of liposome-associated agents injected into normal and tumour-bearing rodents: attempts to improve localization in tumour lines, Life Sci., 21, 357, 10.1016/0024-3205(77)90516-1 Gregoriadis, 1985, Targeting of liposomes to accessible cells in vivo, Ann. New York Acad. Sci., 446, 319, 10.1111/j.1749-6632.1985.tb18411.x Bradfield, 1984, The reticulo-endothelial system and blood clearance, 25 Hoefsmit, 1982, Relation between Langerhans cells, veiled cells and interdigitating cells, Immunobiol., 161, 255, 10.1016/S0171-2985(82)80081-8 Brouwer, 1983, The reticuloendothelial system and aging: a review, Mechanisms Aging Develop., 21, 205, 10.1016/0047-6374(83)90042-8 Lewis, 1976, Phagocytosis in human platelets: localisation of acid-phosphatase-positive phagosomes following latex uptake, Blood, 47, 833, 10.1182/blood.V47.5.833.833 Dobson, 1957, Factors controlling phagocytosis, 97 Lehnert, 1985, Quantitative evaluation of opsonin-independent phagocytosis by alveolar macrophages in monolayer using polystyrene muspheres, J. Immunol. Methods, 78, 337, 10.1016/0022-1759(85)90090-0 Chudwin, 1985, Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae, Infect. Immun., 50, 213, 10.1128/IAI.50.1.213-217.1985 Czop, 1978, Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes, J. Immunol., 120, 1132, 10.4049/jimmunol.120.4.1132 Rouzer, 1981, Dynamics of leukotriene C production by macrophages, J. Exp. Med., 152, 1236, 10.1084/jem.152.5.1236 Schwendener, 1984, The effects of charge and size on the interaction of unilamellar liposomes with macrophages, Biochim. Biophys. Acta, 772, 93, 10.1016/0005-2736(84)90521-2 Abbracchio, 1982, The phagocytosis and transforming activity of crystalline metal sulfide particles are related to their negative surface charge, Carcinogenesis, 3, 175, 10.1093/carcin/3.2.175 Van Oss, 1978, Phagocytosis as surface phenomena, Annu. Rev. Biochem., 46, 669 Saad, 1982, Effects of therapeutic ultrasound on clearance rate of blood borne colloidal particles in vivo, Brit. J. Cancer, 45, 202 Schroit, 1983, Selective delivery of drugs encapsulated in liposomes: natural targeting to macrophages involved in various disease states, J. Biol. Response Modifiers, 2, 97 Territo, 1976, Macrophages and their disorders in man, 593 Lopez-Berenstein, 1983, Treatment or prophylaxis of disseminated infection due to Candida albicans in mice with liposome encapsulated amphotericin B, J. Infect. Dis., 5, 939, 10.1093/infdis/147.5.939 Juliano, 1985, Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infections, Ann. NY Acad. Sci., 446, 390, 10.1111/j.1749-6632.1985.tb18416.x Tadakuma, 1985, Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes, Antimubial Agents Chemotherap., 28, 28, 10.1128/AAC.28.1.28 Fidler, 1986, Immunomodulation of macrophages for cancer and antiviral therapy, 111 Umezawa, 1985, Enzyme replacement with liposomes containing beta-galactosidase from charonia lumpas in murine globoid cell leukodystrophy (Twitcher), Biochem. Biophys. Res. Comm., 127, 663, 10.1016/S0006-291X(85)80212-6 Lynch, 1985, The use of erythrocytes for delivery of chemotherapeutic agents to the reticuloendothelial system, 42 Adams, 1982, Macrophage activation and secretion, 41, 2193 Poste, 1982, Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease, 309 Poste, 1985, Drug targeting in cancer therapy, 427 Davis, 1986, Colloidal delivery systems — opportunities and challenges, 93 Halbert, 1985, A low density lipoprotein-methotrexate covalent complex and its activity against L1210 cells in vitro, Cancer Chemother. Pharmacol., 15, 223, 10.1007/BF00263890 Utsumi, 1983, Inhibition of phagocytosis by erythrocyte membrane sialoglycoprotein on target liposomes, Immunol., 49, 113 Proffitt, 1983, Liposomal blockade of the reticuloendothelial system; improved tumor imaging with small unilamellar vesicles, Science, 220, 502, 10.1126/science.6836294 Allen, 1984, Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution, J. Pharmacol. Exp. Therap., 229, 267 Norde, 1984, Physicochemical aspects of the behaviour of biological components at solid/liquid interfaces, 25 Wilkins, 1966, Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in rat, Brit. J. Exp. Pathol., 47, 569 Napper, 1971, Studies of the steric stabilisation of colloidal particles, J. Colloid Interface Sci., 37, 528, 10.1016/0021-9797(71)90330-4 Ottewill, 1977, Stability and instability in disperse systems, J. Colloid Interface Sci., 58, 357, 10.1016/0021-9797(77)90148-5 Abuchowski, 1977, Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol. Chem., 252, 3578, 10.1016/S0021-9258(17)40291-2 Schon, 1979, Tolerance induction in immediate hypersensitivity, Clin. Allergy, 9, 625, 10.1111/j.1365-2222.1979.tb00489.x Illum, 1986, The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages, Int. J. Pharmaceutics, 29, 53, 10.1016/0378-5173(86)90199-7 Illum, 1983, Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene muspheres following intravenous administration, J. Pharm. Sci., 72, 1086, 10.1002/jps.2600720933 Leu, 1984, Distribution and elimination of coated polymethyl[2- C14]methacrylate nanoparticles after intravenous injections in rats, J. Pharm. Sci., 73, 1433, 10.1002/jps.2600731028 Poznansky, 1983, Enzyme-protein conjugates, 51, 53 Borel, 1980, Haptens bound to self IgG induce immunological tolerance while when coupled to syngenetic spleen cells they induce immune suppression, Immunol. Revs., 50, 71, 10.1111/j.1600-065X.1980.tb00308.x Diner, 1979, Carboxymethyl cellulose, a nonimmunogenic hapten carrier with toleragenic properties, J. Immunol., 122, 1886, 10.4049/jimmunol.122.5.1886 Geyer, 1967, Studies on the metabolism of intravenous fat emulsion, Fette Med., 6, 59 Jeppsson, 1975, The influence of emulsifying agents and lipid soluble drugs on the fractional removal rate of lipid emulsion from the blood stream of the rabbit, Acta Pharmacol. Toxicol., 37, 134, 10.1111/j.1600-0773.1975.tb00830.x Davis, 1985, The influence of emulsifying agents on the phagocytosis of lipid emulsions by macrophages, Int. J. Pharm., 23, 69, 10.1016/0378-5173(85)90223-6 Abuchowski, 1981, Soluble polymer-enzyme adducts, 367 Alpar, 1985, Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes, Biochem. Pharmacol., 34, 257, 10.1016/0006-2952(85)90133-9 Vidal, 1985, Low-density lipoprotein mediated targeting of liposomes to leukemic lymphocytes in vitro, EMBO J., 4, 2461, 10.1002/j.1460-2075.1985.tb03957.x Singhal, 1986, Antibody-mediated targeting of liposomes to red cells in vivo, FEBS Lett, 201, 321, 10.1016/0014-5793(86)80632-9 Laakso, 1986, Acrylic muspheres in vivo, 38, 183 Machy, 1982, Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate, 79, 4148 Stavridis, 1986, Construction of transferrin-coated liposomes for in vivo transport of exogenous DNA to bone marrow erythrocytes in rabbits, J. Exp. Cell. Res., 164, 568, 10.1016/0014-4827(86)90056-X Gallatin, 1983, A cell-surface molecule involved in organ-specific homing of lymphocytes, Nature, 304, 30, 10.1038/304030a0 Butcher, 1986, Interactions between endothelial cells and leucocytes, J. Cell Biochem., 30, 121, 10.1002/jcb.240300204 Auerbach, 1985, Expression of organ-specific antigens on capillary endothelial cells, muvasc. Res., 29, 401 Rutgers, 1986, The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma, 122, 493 Smirnov, 1986, Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall, 83, 6603 Simionescu, 1978, Constitutive endocytosis of the endothelial cell, J. Cell Biol., 79, 381a Aschheim, 1977, Rate of protein extravasation in inflammation, Am. J. Physiol., 206, 327, 10.1152/ajplegacy.1964.206.2.327 Simionescu, 1986, Functions of the endothelial surface, Annu. Rev. Physiol., 48, 279, 10.1146/annurev.ph.48.030186.001431 Mayerson, 1960, Regional differences in capillary permeability, Am. J. Physiol., 198, 155, 10.1152/ajplegacy.1960.198.1.155 Pietra, 1971, Histamine and interstitial pulmonary edema in the dog, Circ. Res., 29, 323, 10.1161/01.RES.29.4.323 Parker, 1985, Plasma-lymph exchange and interstitial distribution volumes of charged macromolecules in the lung, J. Appl. Physiol., 59, 1128, 10.1152/jappl.1985.59.4.1128 Baldwin, 1984, Endothelial transport of anionized and cationized ferritin in the rabbit aorta and vasa vasorum, Arteriosclerosis, 4, 372, 10.1161/01.ATV.4.4.372 Renkin, 1977, Multiple pathways of capillary permeability, Circ. Res., 41, 735, 10.1161/01.RES.41.6.735 Szabo, 1973, The relationship between tissue fluid and lymph, Lymphology, 9, 145 Rennke, 1977, Structural determinants of glomerular permselectivity, 36, 2619 Granger, 1980, Permselectivity of intestinal capillaries, Physiol., 23, 47 Palade, 1979, Structural aspects of the permeability of the muvascular endothelium, Acta Physiol. Scand., 463, 11 Long, 1985, Blood-brain barrier: endogenous modulation by adrenal-cortical function, Science, 227, 1580, 10.1126/science.3975627 Brightman, 1975, Ultrastructural characteristics of adult choroid plexus: relation to the blood-cerebrospinal fluid barrier to proteins, 86 Granger, 1979, Perm-selectivity of the liver blood-lymph barrier to endogeneous macromolecules, Gastroenterology, 77, 103, 10.1016/S0016-5085(79)80018-9 Laine, 1979, Transsinusoidal fluid dynamics in canine liver during venous hypertension, Circ. Res., 45, 317, 10.1161/01.RES.45.3.317 Ghitescu, 1986, Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis, J. Cell. Biol., 102, 1304, 10.1083/jcb.102.4.1304 Vasile, 1983, Visualization of the binding, endocytosis and transcytosis of low-density lipoprotein in the arterial endothelium in situ, J. Cell Biol., 96, 1677, 10.1083/jcb.96.6.1677 Van Berkel, T.J.C., Kruijt, J.K., Harkes, L, Nagelkerke, J.F., Spanjer, H. and Kempen, H.-J.M. Receptor-dependent targeting of native and modified lipoproteins to liver cells. In: E. Tomlinson and S.S. Davis (Eds.), Site-specific Drug Delivery, Cell Biology, Medical and Pharmaceutical Aspects, John Wiley, London, pp. 49–68. Kiwada, 1985, Tissue distribution and pharmacokinetic evaluation of the targeting efficiency of synthetic alkyl glycoside vesicles, Chem. Pharm. Bull., 33, 2465, 10.1248/cpb.33.2475 Lees, 1985, Technetium-99m low density lipoproteins: preparation and biodistribution, J. Nucl. Med., 26, 1057 Jefferies, 1984, Transferrin receptor on endothelium of brain capillaries, Nature, 312, 1162, 10.1038/312162a0 Hill, 1985, Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution, 82, 4553 Westergaard, 1979, Transfer of muperoxidase in vesicles across cerebral endothelium in adult mice, Neorosci. Lett., S56 Seitz, 1985, The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system, Acta Neuropath. (Berlin), 68, 15, 10.1007/BF00688950 Shoji, 1985, Electron muscopic studies on tissue distribution of lipid muspheres used as drug delivery carriers, Drugs Exp. Clin. Res., 11, 601 Mizushima, 1983, Anti-inflammatory effects of indomethacin ester incorporated in a lipid musphere, J. Pharm. Pharmacol., 35, 398, 10.1111/j.2042-7158.1983.tb02969.x Cleland, 1982, Cortisol palmitate liposomes: enhanced antiinflammatory effect in rats compared with free cortisol, Agents Actions, 12, 348, 10.1007/BF01965402 Hoshi, 1985, Double-blind study with liposteroid in rheumatoid arthritis, Drugs Exp. Clin. Res., XI, 621 Arfors, 1979, muvascular transport of macromolecules in normal and inflammatory conditions, Acta Physiol. Scand, 463, 93 Williams, 1986, Imaging in rheumatoid arthritis using liposomes labelled with technetium, Brit. Med. J., 293, 1143, 10.1136/bmj.293.6555.1143-a Jellinek, 1969, Investigations of the permeability changes of the vascular wall in experimental malignant hypertension by means of a colloidal iron preparation, Brit. J. Exp. Pathol., 50, 13 Palmer, 1981, Liposome accumulation in ischaemic intestine following experimental mesenteric occlusion, BioSci. Rep., 1, 337, 10.1007/BF01114873 Mueller, 1981, Liposome concentration in canine ischemic myocardium and depolarized myocardial cells, Circ. Res., 49, 405, 10.1161/01.RES.49.2.405 Majack, 1980, Endothelial alterations and colloidal carbon permeability in the peripheral vasculature of the spontaneously hypertensive rat, Exp. Mol. Pathol., 32, 201, 10.1016/0014-4800(80)90055-6 Widder, 1981, Tumor remission in Yoshida sarcoma-bearing rats by selective targeting of magnetic albumin muspheres containing doxorubicin, 78, 579 Akimoto, 1985, Application of magnetic emulsions for sustained release and the targeting of drugs in cancer chemotherapy, J. Controlled Release, 1, 205, 10.1016/0168-3659(85)90019-7 Rettenmaier, 1985, In vivo alteration of RES phagocytosis by magnetic albumin muspheres, J. Clin. Lab. Immunol., 17, 99 Mohan, 1986, Macromolecular organisation of basement membranes, 261, 4328 Kanwar, 1980, Increased permeability of the glomerular basement membrane to ferritin after the removal of glycosaminoglycans (heparan sulphate) by enzyme digestion, J. Cell. Biol., 86, 688, 10.1083/jcb.86.2.688 Newman, 1985, Matrix-driven translocation of cells and non-living particles, Science, 228, 885, 10.1126/science.4001925 Carroll, 1984, Receptor-mediated radiopharmaceuticals, 39 Brown, 1985, The LDL receptor and the regulation of cellular cholesterol metabolism, J. Cell Sci Suppl., 3, 131 1984 1987, Mapping the human genome, Lancet, 1, 1121 Wilson, 1986, Gene therapy: rational and realisation, 149 Weiss, 1982, Experimental biology and assay of retroviruses, 209 Nicolau, 1980, vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I, 80, 1068 Broder, 1987, Strategies for experimental therapy of the retrovirus which causes AIDS, Ann. Inst. Pasteur/Virol., 138, 49, 10.1016/S0769-2617(87)80074-6 1987, Biotechnology Newswatch, 7, 5 President and fellows of Harvard College, 1987 Teijen Ltd., 1987 Strejan, 1981, Naturally occurring antibodies to liposomes, 127, 160 Levin, 1980, Heuristic modeling of drug delivery to malignant brain tumours, J. Pharmacokinetics Biopharm., 8, 257, 10.1007/BF01059646 Hagan, 1986, Tumor size: effect on monoclonal antibody uptake in tumor models, J. Nucl. Med., 27, 422 Embleton, 1986, Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targeting, Int. J. Cancer, 38, 821, 10.1002/ijc.2910380607 Vitetta, 1986, Immunotoxins: the development of new strategies for treating B cell tumours, 69 Thiesen, 1987, Selective killing of human bladder cancer cells by combined treatment with A and B chain ricin antibody conjugates, Cancer Res., 47, 419 Blakey, 1986, Effect of chemical deglycosylation on the in vivo fate of ricin A-chain, Cancer Drug Delivery, 3, 189, 10.1089/cdd.1986.3.189 Jayarana, 1981, Selective inhibition of E. coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3′ end of 168r RNA, 78, 1537 Tomlinson, 1986, New delivery systems for therapeutic agents, 39 Allen, 1987, Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid A compared with empty liposomes, Can. J. Physiol. Pharmacol., 65, 185, 10.1139/y87-035 Szymendera, 1977, Pathologic changes in the lungs of mice following injection of human albumin muspheres, J. Nucl. Med., 18, 478 Schreier, 1987, Murine plasma fibronectin depletion after intravenous injection of liposomes, Int. J. Pharmaceutics, 37, 233, 10.1016/0378-5173(87)90034-2 Tlaskalová-Hogenová, 1985, vivo and in vitro immunogenicity of water-soluble haptenated copolymers for mouse and human lymphocytes, Makromol. Chem., 137, 10.1002/macp.1985.020091985118 Šimečková, 1986, The activity of complement in the presence of N-(2-hydroxypropyl)methacrylamide copolymers, J. Bioactive Compat. Polym., 1, 20, 10.1177/088391158600100103 Harkinen, 1987, Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin-A chain immunotoxin in rats, Cancer Res., 47, 1377 Benet, 1986, Temporal and pharmacokinetic aspects in delivery of peptides and proteins, 79 Hunt, 1986, Engineered targeted in vivo drug delivery, 3, 333 Sezaki, 1984, Macromolecule-drug conjugates in targeted cancer chemotherapy, CRC Crit. Revs. Therap. Drug Carrier Syst., 1, 1 Denson, 1986, Use of a limited physiologic model to explain target organ toxicity of bupivacaine as a function of route of administration, Biopharm. Drug Dispos., 7, 121, 10.1002/bdd.2510070204 1986 Edmond, 1986, Monoclonal antibodies as drugs or devices: practical and regulatory aspects, Drug Dev. Ind. Pharm., 12, 107, 10.3109/03639048609048022 Greenstein, 1985, Controlling the bugs, 11, 489 Schiff, 1986, Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte, J. Cell Biol., 102, 920, 10.1083/jcb.102.3.920 Chernyavskii, 1985, Liposomes as a carrier of genetic information, Molek. Genetika. Mikrobiol. Virusol., 3 Glushakova, 1985, Optimal transfer and incorporation of viral DNA into cells via liposomes containing virus glycoproteins, Molek. Genet., Mikrobiol. Virusol., 32 Citovsky, 1985, Fusion of Sendai virions with phosphatidylcholine-cholesterol liposomes reflects the viral activity required for fusion with biological membranes, FEBS Lett., 193, 135, 10.1016/0014-5793(85)80137-X Treleaven, 1984, Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic muspheres, Lancet, 70, 10.1016/S0140-6736(84)90004-7 Knudsen, 1986, Protection of guinea pigs against local and systemic foot-and-mouth disease after administration of synthetic lipid amine (Avridine) liposomes, Antiviral Res., 6, 123, 10.1016/0166-3542(86)90032-X LeMaitre, 1987, Specific antiviral activity of a poly(l-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site, 84, 648 Fiume, 1986, Drug targeting in antiviral chemotherapy, 35, 967 Dolce, 1987, Systemic clearance of amphotericin B delivered in a parenteral lipid emulsion to rats, Clin. Pharmacol. Ther., 41, 166